- Previous Close
5,410.00 - Open
5,480.00 - Bid 5,300.00 x --
- Ask 5,310.00 x --
- Day's Range
5,290.00 - 5,480.00 - 52 Week Range
4,730.00 - 10,940.00 - Volume
25,479 - Avg. Volume
255,613 - Market Cap (intraday)
103.65B - Beta (5Y Monthly) 0.65
- PE Ratio (TTM)
-- - EPS (TTM)
-- - Earnings Date --
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
--
KoBioLabs, Inc. provides microbiome therapeutics for metabolic, immune, and neurological diseases. The company is based in Seongnam-si, South Korea.
kobiolabs.comRecent News: 348150.KQ
View MorePerformance Overview: 348150.KQ
Trailing total returns as of 1/17/2025, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: 348150.KQ
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: 348150.KQ
View MoreValuation Measures
Market Cap
104.81B
Enterprise Value
63.85B
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
1.68
Price/Book (mrq)
2.56
Enterprise Value/Revenue
1.04
Enterprise Value/EBITDA
--
Financial Highlights
Profitability and Income Statement
Profit Margin
-21.31%
Return on Assets (ttm)
-7.58%
Return on Equity (ttm)
-16.09%
Revenue (ttm)
52.08B
Net Income Avi to Common (ttm)
-11.1B
Diluted EPS (ttm)
--
Balance Sheet and Cash Flow
Total Cash (mrq)
57.63B
Total Debt/Equity (mrq)
27.99%
Levered Free Cash Flow (ttm)
-22.56B